Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Wouter Jukema

Showing results (631-640 of 927) with videos related to

Pageof 93
Sort By:
Journal of the American Heart Association|April 25, 2019
Metabolomics Profiling of Visceral Adipose Tissue: Results From MESA and the NEO StudyIan J Neeland, Sebastiaan C Boone, Dennis O Mook-Kanamori, et al.
Journal of Clinical Lipidology|September 24, 2022
Relation of red blood cell distribution width to risk of major adverse cardiovascular events, death, and effect of alirocumab after acute coronary syndromesPatrick M Moriarty, Philippe Gabriel Steg, Jennifer McGinniss, et al.
The American Journal of Medicine|March 17, 2022
Effect of Alirocumab on Incidence of Atrial Fibrillation After Acute Coronary Syndromes: Insights from the ODYSSEY OUTCOMES TrialRenato D Lopes, Patrícia O Guimarães, Gregory G Schwartz, et al.
The American Journal of Cardiology|October 24, 2025
Clinical and Technical Predictors of Adverse Cardiovascular Events Following Coronary Lithotripsy in the BENELUX-IVL RegistryMartijn J H van Oort, Akshay A S Phagu, Federico Oliveri, et al.
The American Journal of Cardiology|July 24, 2025
Procedural and Clinical Outcomes of Coronary Intravascular Lithotripsy in Patients With Impaired Renal Function: A Multicenter Retrospective StudyAkshay A S Phagu, Martijn J H van Oort, Federico Oliveri, et al.
Cardiovascular Drugs and Therapy|June 21, 2013
Long term effects of epoetin alfa in patients with ST- elevation myocardial infarctionMarieke L Fokkema, Lennaert Kleijn, Peter van der Meer, et al.
American Heart Journal|November 5, 2025
Evolocumab before percutaneous coronary intervention for acute myocardial infarction: Design of the AMUNDSEN trialGilles Montalescot, Leonardo Bolognese, Stanislaw Bartus, et al.
JAMA Cardiology|April 30, 2020
An Exploratory Analysis of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibition and Aortic Stenosis in the FOURIER TrialBrian A Bergmark, Michelle L O'Donoghue, Sabina A Murphy, et al.
Circulation. Cardiovascular Imaging|July 28, 2010
Predictive value of multislice computed tomography variables of atherosclerosis for ischemia on stress-rest single-photon emission computed tomographyJoëlla E van Velzen, Joanne D Schuijf, Jacob M van Werkhoven, et al.
Journal of Neurology|August 5, 2009
Pravastatin and cognitive function in the elderly. Results of the PROSPER studyStella Trompet, Peter van Vliet, Anton J M de Craen, et al.
Pageof 93

Showing results (631-640 of 927) with videos related to

Sort By:
Pageof 93
Journal of the American Heart Association|April 25, 2019
Metabolomics Profiling of Visceral Adipose Tissue: Results From MESA and the NEO StudyIan J Neeland, Sebastiaan C Boone, Dennis O Mook-Kanamori, et al.
Journal of Clinical Lipidology|September 24, 2022
Relation of red blood cell distribution width to risk of major adverse cardiovascular events, death, and effect of alirocumab after acute coronary syndromesPatrick M Moriarty, Philippe Gabriel Steg, Jennifer McGinniss, et al.
The American Journal of Medicine|March 17, 2022
Effect of Alirocumab on Incidence of Atrial Fibrillation After Acute Coronary Syndromes: Insights from the ODYSSEY OUTCOMES TrialRenato D Lopes, Patrícia O Guimarães, Gregory G Schwartz, et al.
The American Journal of Cardiology|October 24, 2025
Clinical and Technical Predictors of Adverse Cardiovascular Events Following Coronary Lithotripsy in the BENELUX-IVL RegistryMartijn J H van Oort, Akshay A S Phagu, Federico Oliveri, et al.
The American Journal of Cardiology|July 24, 2025
Procedural and Clinical Outcomes of Coronary Intravascular Lithotripsy in Patients With Impaired Renal Function: A Multicenter Retrospective StudyAkshay A S Phagu, Martijn J H van Oort, Federico Oliveri, et al.
Cardiovascular Drugs and Therapy|June 21, 2013
Long term effects of epoetin alfa in patients with ST- elevation myocardial infarctionMarieke L Fokkema, Lennaert Kleijn, Peter van der Meer, et al.
American Heart Journal|November 5, 2025
Evolocumab before percutaneous coronary intervention for acute myocardial infarction: Design of the AMUNDSEN trialGilles Montalescot, Leonardo Bolognese, Stanislaw Bartus, et al.
JAMA Cardiology|April 30, 2020
An Exploratory Analysis of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibition and Aortic Stenosis in the FOURIER TrialBrian A Bergmark, Michelle L O'Donoghue, Sabina A Murphy, et al.
Circulation. Cardiovascular Imaging|July 28, 2010
Predictive value of multislice computed tomography variables of atherosclerosis for ischemia on stress-rest single-photon emission computed tomographyJoëlla E van Velzen, Joanne D Schuijf, Jacob M van Werkhoven, et al.
Journal of Neurology|August 5, 2009
Pravastatin and cognitive function in the elderly. Results of the PROSPER studyStella Trompet, Peter van Vliet, Anton J M de Craen, et al.
Pageof 93